HIV research collaboration in Uganda to prevent mother-to-child transmission and improve adult HIV treatment
Official title: The Johns Hopkins University - Uganda Clinical Trials Unit
Funded at Johns Hopkins University · NIH-11607147 · Data updated 2026-11-12
This grant supports Johns Hopkins to run Uganda clinical trial sites that test new HIV prevention and treatment approaches, helping diverse adults and mothers-to-be in Uganda access cutting-edge care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | February 5, 2007 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $291,156 |
| NIH project number | 3UM1AI069530-20S5 |
| Project ID | NIH-11607147 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV and at-risk HIV-negative women, including those in high-prevalence urban, peri-urban, and rural communities in Kampala and Rakai.
✕Less likely to help
Individuals not engaged in HIV prevention or treatment trials or those outside the study sites may not directly benefit.
What this research studies
The project continues a long-standing collaboration between Johns Hopkins and Ugandan clinical sites to run HIV prevention and treatment trials. It aims to expand network affiliations and add new sites to enroll adults and at-risk populations in Kampala and Rakai Districts. The work focuses on PMTCT, pediatric HIV treatment, adult HIV therapeutics, and HIV vaccines, with plans to partner with multiple DAIDS-funded networks. By increasing participation and access, it seeks to accelerate the development of effective interventions for people living with HIV and those at high risk. This renewal emphasizes leveraging prior success to broaden reach and impact in diverse real-world settings.
Why it matters
Potential benefit: If successful, patients could benefit from faster access to new HIV prevention and treatment options and improved care strategies in Uganda and similar settings.
How similar studies have gone: Previous work by JHU-CTU has demonstrated feasibility and impact in PMTCT and HIV prevention/treatment trials in Uganda.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Fowler, Mary Glenn — Johns Hopkins University
- Study coordinator: Fowler, Mary Glenn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.